In this issue:
Dipeptidyl peptidase-4 inhibitors and incidence of IBD
Interactions of thiopurine metabolites, adalimumab and adalimumab antibodies
Adjunctive allopurinol in azathioprine/mercaptopurine nonresponders
Risk of lymphoma with thiopurines and TNF antagonists
UK trends in endoscopic, medical and surgical IBD admissions
Combination immunosuppression in IBD
Tight control management of CD
Sports participation in youth with IBD
Sexual dysfunction in men with IBD
Science Blog: Intestinal ischaemia and hydroxylase inhibitors
Please login below to download this issue (PDF)